900m lives depend on livestock

GALVmed makes livestock vaccines, medicines and diagnostics accessible and affordable to the millions in developing countries for whom livestock is a lifeline

About GALVmed

Neurocysticercosis, a human disease transmitted from pigs with porcine cysticercosis (PC), causes 30% of human epilepsy cases in the developing world.

The disease is estimated to cause around 5 million human cases and 50,000 human deaths each year.

This is a disease that affects the poor and those who have neurocysticercosis are often stigmatised in their communities.

The first-ever licensed PC vaccine became available in India at the end of 2016 at US $1 for 2 doses to vaccinate a pig.

Tackling the major cause of epilepsy in the developing world

Our work

Product development

GALVmed specialises in product development partnerships uniquely established to translate global research progress into tangible livestock disease control tools for the developing world.

Market development

Our work with our partners supports the poor livestock keepers of the world.

Policy and advocacy

The policy environment is a key determinant in the successful translation of research products to livestock health solutions that are sustainably available to smallholder farmers.


Creating innovative livestock health care products & services targeted to smallholder farmers

Livestock production in smallholder systems exists throughout the developing world. Livestock contributes considerably to the livelihood strategies of the poor and can be an important source of income and nutrition.

However, smallholder farmers consistently battle livestock …

How Brucellosis infection can impact the food chain

GALVmed is implementing AgResults’ US $30 million Brucellosis Vaccine Prize competition, aimed at incentivising the development of a suitable vaccine that is efficacious, safe and viable for use against Brucella melitensis in small ruminants across …

Indigenous poultry keeping is a growing business in rural western Kenya

Increased access to Newcastle disease (ND) vaccine, especially the thermo-tolerant I-2 ND, is boosting backyard indigenous poultry farming in Ugunja, a small market town in Siaya County, Kenya – near the Ugandan border. The I-2 …